Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Current Assets (2016 - 2026)

Cryo Cell International's Current Assets history spans 17 years, with the latest figure at $11.1 million for Q1 2026.

  • Quarterly results put Current Assets at $11.1 million for Q1 2026, down 11.45% from a year ago — trailing twelve months through Feb 2026 was $11.1 million (down 11.45% YoY), and the annual figure for FY2025 was $11.8 million, down 6.34%.
  • Current Assets for Q1 2026 was $11.1 million at Cryo Cell International, down from $11.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $13.1 million in Q2 2025 to a low of $9.5 million in Q1 2024.
  • The 5-year median for Current Assets is $10.6 million (2023), against an average of $10.8 million.
  • The sharpest move saw Current Assets tumbled 48.03% in 2022, then soared 32.81% in 2024.
  • Year by year, Current Assets stood at $9.6 million in 2022, then decreased by 1.64% to $9.5 million in 2023, then soared by 32.81% to $12.6 million in 2024, then dropped by 6.34% to $11.8 million in 2025, then fell by 5.79% to $11.1 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods came in at $11.1 million, $11.8 million, and $11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.